13F HOLDINGS REPORT
Vantage Consulting Group Inc
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001172661-24-004815
Total Value
$11.4M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BABCOCK & WILCOX ENTERPRISES | BW-PA | 2,416,200 | $4.9M | 43.18% |
| 2 | CIBUS INC | CBUS | 1,143,949 | $3.7M | 32.67% |
| 3 | ADC THERAPEUTICS SA | ADCT | 850,737 | $2.7M | 23.47% |
| 4 | FIBROGEN INC | 31572Q808 | 195,707 | $78,165 | 0.68% |